Ever Source Wealth Advisors, LLC Zentalis Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $2.2 Billion
- Q3 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,593 shares of ZNTL stock, worth $3,448. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,593
Previous 2,350
10.34%
Holding current value
$3,448
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ZNTL
# of Institutions
106Shares Held
57.9MCall Options Held
0Put Options Held
43.4K-
Matrix Capital Management Company, LP Waltham, MA14MShares$18.6 Million33.01% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$3.86 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.85MShares$3.78 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.33MShares$3.09 Million0.0% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $75.8M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...